![European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies](https://www.ecco-ibd.eu/images/6_Publication/6_2_ECCO_News/ECCO_News_Images/2021_Issue_3/Nestle/Graphic%203_ECCO.png)
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
![Frontiers | Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis Frontiers | Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis](https://www.frontiersin.org/files/Articles/837294/fmed-09-837294-HTML-r2/image_m/fmed-09-837294-g001.jpg)
Frontiers | Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis
![How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - Clinical Gastroenterology and Hepatology How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - Clinical Gastroenterology and Hepatology](https://www.cghjournal.org/cms/asset/5da7788d-f6f5-4db4-8b0e-1806a0261d61/gr1.jpg)
How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - Clinical Gastroenterology and Hepatology
![PDF] Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. | Semantic Scholar PDF] Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/434bc5078bbc62a1a4782f27592fcf28f239679e/8-Table1-1.png)
PDF] Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. | Semantic Scholar
![Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study](https://www.frontiersin.org/files/Articles/851295/fpubh-10-851295-HTML-r1/image_m/fpubh-10-851295-g001.jpg)
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
![Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU | Gastroenterología y Hepatología Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU | Gastroenterología y Hepatología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S021057051200307X:gr6.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNcRcp7AE8pxI7/lU7i5mKGl6o67DY/uL2+/IxZemV5MIklFRSF018ujqY31bChr6pFFPpzKAlZflw3pzZHWf24+HJpunzetR+USy+pZ8qTKeqEh1dDEX84sbcPicc7/sqMSgmOEHYpiPZ4us/jF5Fak8rMh8KoSgjXM1Bv+ra2ZFtN7CGqnLEbskFKHbcaHfnwkuQUDU6Y2s77zwqkusyCLRqzkg7Obn8+O6d4cGpCkbPLZ2c9s7MNnYbMgqDXJ/8Q=)
Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU | Gastroenterología y Hepatología
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical M
![The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial - The Lancet Gastroenterology & Hepatology The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/f2ebb762-f98f-4396-bb20-e93779b13701/gr1.gif)
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial - The Lancet Gastroenterology & Hepatology
![Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease](https://www.mdpi.com/life/life-11-01375/article_deploy/html/images/life-11-01375-g001.png)
Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
![JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis](https://www.mdpi.com/jcm/jcm-11-02302/article_deploy/html/images/jcm-11-02302-g001.png)
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
![Transmural remission improves clinical outcomes up to 5 years in Crohn's disease - Fernandes - United European Gastroenterology Journal - Wiley Online Library Transmural remission improves clinical outcomes up to 5 years in Crohn's disease - Fernandes - United European Gastroenterology Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/992237ae-3924-474d-9af7-140190435a8e/ueg212356-toc-0001-m.jpg)